D Dalmau
Overview
Explore the profile of D Dalmau including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
21
Citations
161
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sanmarti M, Meyer A, Jaen A, Robertson K, Tan N, Mapesi H, et al.
HIV Med
. 2020 Nov;
22(2):102-112.
PMID: 33190352
Objectives: Few studies have assessed cognitive impairment among healthy people living with HIV (PLWH) who are stable on antiretroviral treatment (ART) in sub-Saharan Africa. Methods: We conducted a cross-sectional study...
2.
Nicolas D, Esteve A, Cuadros A, Campbell C, Tural C, Podzamczer D, et al.
Clin Infect Dis
. 2016 Apr;
62(12):1578-1585.
PMID: 27126346
Background: It has been suggested that routine CD4 cell count monitoring in human immunodeficiency virus (HIV)-monoinfected patients with suppressed viral loads and CD4 cell counts >300 cell/μL could be reduced...
3.
Hofstra L, Sauvageot N, Albert J, Alexiev I, Garcia F, Struck D, et al.
Clin Infect Dis
. 2015 Dec;
62(5):655-663.
PMID: 26620652
Background: Numerous studies have shown that baseline drug resistance patterns may influence the outcome of antiretroviral therapy. Therefore, guidelines recommend drug resistance testing to guide the choice of initial regimen....
4.
Gimenez N, Jodar E, Torres M, Dalmau D
Rev Calid Asist
. 2009 Sep;
24(6):245-55.
PMID: 19761742
Unlabelled: Biomedical research is a necessary subject and enjoys social prestige. Aims: To ascertain the views and expectations of health care professionals on research, analysing the influence of their academic...
5.
Imaz A, Falco V, Penaranda M, Jordano Q, Martinez X, Nadal C, et al.
HIV Med
. 2009 Jun;
10(6):356-63.
PMID: 19490180
Background: Recent studies in hospitalized patients with community-acquired pneumonia have found a lower risk of bacteraemia and better clinical outcomes in patients who had previously received the 23-valent pneumococcal polysaccharide...
6.
Mallolas J, Blanco J, Pich J, Arnaiz J, Pena J, Dalmau D, et al.
Rev Clin Esp
. 2007 Oct;
207(9):427-32.
PMID: 17915162
Background: The use of HAART combining 2 nucleoside analogues reverse transcriptase inhibitors (NRTIs) plus one protease inhibitor (PI) or 2 NRTIs + 1 non-nucleoside reverse transcriptase inhibitor (NNRTI) has shown...
7.
Mallolas J, Blanco J, Labarga P, Vergara A, Ocampo A, Sarasa M, et al.
HIV Med
. 2007 Apr;
8(4):226-33.
PMID: 17461850
Background: The addition of a low dose of ritonavir to protease inhibitors (PIs) has become a widespread strategy to improve PI pharmacokinetics. As resistance is a major barrier to long-term...
8.
Gallego O, de Mendoza C, Perez-Elias M, Guardiola J, Pedreira J, Dalmau D, et al.
AIDS
. 2001 Sep;
15(13):1701-6.
PMID: 11546946
Objective: To assess the pattern of drug resistance mutations selected in HIV-1-infected patients failing a first line triple combination therapy including indinavir. Patients And Methods: Plasma samples from 87 patients...
9.
Garcia F, Alonso M, Romeu J, Knobel H, Arrizabalaga J, Ferrer E, et al.
J Acquir Immune Defic Syndr
. 2000 Nov;
25(1):26-35.
PMID: 11064501
The objective of antiretroviral therapy is to obtain an almost complete and durable suppression of viral replication in all compartments to facilitate recovery of the immune system. We assessed the...
10.
Garcia F, Knobel H, Sambeat M, Arrizabalaga J, Aranda M, Romeu J, et al.
AIDS
. 2000 Jan;
14(16):2485-94.
PMID: 11101059
Objectives: To evaluate the safety and effectiveness of once-daily didanosine and nevirapine plus twice-daily stavudine versus twice-daily administration of all three drugs. Methods: This open-label, randomized, multicentre study enrolled 94...